title: Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach.
authors.affiliation: Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada. Electronic address: Jacques-P.Tremblay@crchul.ulaval.ca.
authors.forename: Jacques P
authors.initials: JP
authors.lastname: Tremblay
authors.affiliation: Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada.
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Iyombe-Engembe
authors.affiliation: Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Duchêne
authors.affiliation: Centre de Recherche du CHU de Québec-Université Laval, Quebec, Quebec, Canada.
authors.forename: Dominique L
authors.initials: DL
authors.lastname: Ouellet
mesh_terms: D000818:Animals; D064113:CRISPR-Cas Systems; D064112:Clustered Regularly Interspaced Short Palindromic Repeats; D016189:Dystrophin; D000072669:Gene Editing; D006801:Humans; D051379:Mice; D018101:Mice, Inbred mdx; D020388:Muscular Dystrophy, Duchenne / Q000235:genetics* / Q000628:therapy
chemical_list: D016189:Dystrophin